News blog

Omega Diagnostics

  • BY: Andrew Hore |
  • POSTED: 22/04/2019 |

Allergy and infectious diseases tests developer Omega Diagnostics says that second half trading was slightly better than expected.

Revenues were 28% lower at £9.76m in the year to March 2019 and there was a small second half profit. Like-for-like revenues did improve by 3%. The full year was still loss-making. Net debt was £900,000.

Food intolerance revenues grew but other parts of the business declined.

VISITECT CD4 has achieved the CE Mark and a dossier will be submitted to the expert review panel for diagnostics this month. Approval will enable NGOs to procure the VISITECT CD4 disease test.

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Quoted Micro 20 May 2019

Continue reading... | 20/05/2019

Tricorn Group

Engineer Tricorn has invested $50,000 in a fully operational powder coat and wet spray painting line in Georgia.

Continue reading... | 20/05/2019

LiDCO Group

Patient monitoring equipment developer and supplier LiDCO Group says that first quarter trading was better than expected. 

Continue reading... | 20/05/2019

Quoted Micro 13 May 2019

Continue reading... | 13/05/2019

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds